Companies · Retailing

Rarebird, Inc.Summer 2020Active

SAN FRANCISCO · CA, USA · Retailing · founded 2020 · http://www.rarebird.coffee

Diligence memoA one-page analyst read on Rarebird, Inc. — recommendation, valuation, rhythm, risks.
$9.0M
Total raised · real
4
Rounds
10.0×
Latest step-up
Top 22%
Sector rank · raised
Series A
Latest stage · inferred · Fri Oct 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

Rarebird, Inc. looks under-valued against its niche peers and is quiet on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the retail sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.16× the median modeled value of Series A Retailing companies in 2022–2024 (100 peers) — value vs value, same stage and era.
Quiet
  • Last raise 21 mo ago; this sector typically re-raises about every 13 months.
  • Slightly overdue versus sector cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Retailing

Rarebird, Inc. is one of 2347 Retailing companies tracked from SAN FRANCISCO, CA, USA, on record since 2020. By capital raised it ranks in the upper tier (ahead of 79% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

AI analyst read est. — model-extracted from this company's public description, not a verified fact. 30%

operates a technology-led product inferred from public copy

Grounded in: “You are a venture analyst

Elevating mental health to be a part of your daily coffee ritual.

We are making coffee for caffeine sensitive people. We do this by producing the world's first caffeine replacement, paraxanthine. It's better than caffeine at waking you up and causes fewer side effects, like anxiety and jitteriness.

HealthcareIndustrial Bio
Find Rarebird, Inc. online

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
1
Investors (latest)
2020
Year incorporated
2024-10-11
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$13M$25M$38M$50MSeries A · 2023-07-14 Raised $6.5M (real) Modeled valuation $22M (est)$6.5M$22MSeries A2023Series A · 2023-09-05 Raised $400K (real) Modeled valuation $1.3M (est)$400K$1.3MSeries A2023Series A · 2023-12-18 Raised $1.1M (real) Modeled valuation $3.6M (est)$1.1M$3.6MSeries A2023Pre-Seed · 2023-12-18 Raised $100K (real) Modeled valuation $302K (est)$100K$302KPre-Seed2023Series A · 2024-10-11 Raised $1.0M (real) Modeled valuation $2.9M (est)$1.0M$2.9MSeries A2024+$400K+$1.1M+$100K+$1.0MCumulative $9.1M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series A$6.5M · 2023
Series A extension$400K · 2023
Series A extension$1.1M · 2023
Bridge · Series A-stage$100K · 2023smaller follow-on
Series A extension$1.0M · 2024

Stages are modeled from round size (public records carry no series label). No record for: Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 67%.

Modeled valuation trajectory
$2.9M
Base estimate est.
$1.2M
Conservative case
$5.8M
Upside case
$4.5M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the retail sector profile. Directional, not a quoted figure.

Series A · modeled $22.1M · 2023-07-142023Series A · modeled $1.3M · 2023-09-05Series A · modeled $3.6M · 2023-12-18Pre-Seed · modeled $302K · 2023-12-18Series A · modeled $2.9M · 2024-10-112024
Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
50%
Survival probability
27% low · 68% high
1.15×/yr
Annual markup
1.45×/yr upside case
1.7 yr
Elapsed time used
1.7 yr actual, capped for stale marks
retail
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
4 mo
Avg between rounds
$7.3M/yr
Capital velocity
3.0 yr
On record since
2023
First round
5
Rounds on file
How it compares to the market

Benchmarked against 2347 companies in Retailing. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 5.7× above median
This company$9.0M
Sector median$1.6M
Latest round — vs other Series A rounds in sector (real $, this stage) 0.2× of median
This company$1.0M
Sector median$5.5M
Modeled value — vs sector median (estimate, all stages) 0.5× of median
This company$2.9M
Sector median$5.8M

Raised more than 79% of sector peers (real $). Modeled value above 35% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #97 of 100.

This companyCohort peer
$1.0M$10.0M$100.0M$1.0M$10.0M$100.0MCapital raised (log)Olivela Inc. · Series A Raised $28.8M · modeled $61.1M (est)PSP Investors, LLC · Series A Raised $15.4M · modeled $53.4M (est)Coreleap, Inc. · Series A Raised $16.7M · modeled $52.0M (est)Cariloha, Inc. · Series A Raised $22.5M · modeled $51.2M (est)Elevation Cannabis, LLC · Series A Raised $15.0M · modeled $47.6M (est)Botany Bay Wax Co LLC · Series A Raised $13.3M · modeled $45.8M (est)Full Glass Wine Co., LLC · Series A Raised $14.2M · modeled $44.2M (est)Kafene, Inc. · Series A Raised $42.1M · modeled $43.2M (est)Skinny Butcher LLC · Series A Raised $10.0M · modeled $41.6M (est)G2G Ventures, PBC · Series A Raised $13.4M · modeled $38.5M (est)YCP Car Wash Portfolio LLC · Series A Raised $12.6M · modeled $37.9M (est)Elevation Bridge, LLC · Series A Raised $12.0M · modeled $35.9M (est)Rarebird, Inc. (this company) Raised $9.0M · modeled $2.9M (est)Rarebird, Inc.
CompanyStageRaised · realValue · estvs peer med.
Olivela Inc.Series A$28.8M$61.1M3.35×
PSP Investors, LLCSeries A$15.4M$53.4M2.93×
Coreleap, Inc.Series A$16.7M$52.0M2.85×
Cariloha, Inc.Series A$22.5M$51.2M2.81×
Elevation Cannabis, LLCSeries A$15.0M$47.6M2.61×
Botany Bay Wax Co LLCSeries A$13.3M$45.8M2.52×
Full Glass Wine Co., LLCSeries A$14.2M$44.2M2.43×
Kafene, Inc.Series A$42.1M$43.2M2.37×
Skinny Butcher LLCSeries A$10.0M$41.6M2.29×
G2G Ventures, PBCSeries A$13.4M$38.5M2.12×
YCP Car Wash Portfolio LLCSeries A$12.6M$37.9M2.08×
Elevation Bridge, LLCSeries A$12.0M$35.9M1.97×
Rarebird, Inc. this companySeries A$9.0M$2.9M0.16×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series A$6.5M2023-07-14$29.6M$22.1M90%
Series A$400K2023-09-05$1.8M$1.3M90%
Series A$1.1M2023-12-18$5.1M$3.6M90%
Pre-Seed$100K2023-12-18$556K$302K90%
Series A$1.0M2024-10-11$4.5M$2.9M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series A$6.5M2023-07-14
    • First recorded raise — entered as Series A.
    • 27 investors on this round.
  2. Series A$400K2023-09-05
    • Came back fast: 2 mo vs the ~13 mo sector norm.
    • Round 16.3× smaller than the prior — bridge or down round.
    • 2 investors on this round.
  3. Series A$1.1M2023-12-18
    • Came back fast: 3 mo vs the ~13 mo sector norm.
    • Round 2.8× larger than the prior — scaling up.
    • 4 investors on this round.
  4. Pre-Seed$100K2023-12-18
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 11.2× smaller than the prior — bridge or down round.
    • 1 investor on this round.
  5. Series A$1.0M2024-10-11
    • Raised 10 mo later, in step with the ~13 mo sector norm.
    • Round 10.0× larger than the prior — scaling up.
    • 1 investor on this round.
Intelligence
2025 ~Q1
Modeled next raise · ~4mo cadence
$3.0M
Modeled next size est.range $2.0M$4.8M
10.0×
Last step-up
$7.3M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Jeffrey Dietrich1 other2023-07
Ann Dunn Andracchio2023-07
Registry & provenance

Rarebird, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1987368
SEC CIK
2020
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
JB-NY Distributors, Inc.RetailingSeries A$9.4M$2.2Msame sector · same stage
Shinesty, Inc.RetailingSeries A$9.9M$3.1Msame sector · same stage
Tatyana Designs, Inc.RetailingSeries A$10.5M$2.0Msame sector · same stage
Espresso Bookstore & Cafe Holdings LLCRetailingSeries A$10.7M$3.1Msame sector · same stage
Blue Stripe, LLCRetailingSeries A$7.0M$3.1Msame sector · same stage
Green PolkaDot Box IncRetailingSeries A$11.8M$2.4Msame sector · same stage
KeyView Labs, Inc.RetailingSeries A$12.9M$2.6Msame sector · same stage
Seedling Holdings, Inc.RetailingSeries A$13.0M$3.9Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Craft Coffee
Better coffee for less money
Agtech / Foodtech68%
Buy Me a Coffee
Helping creators monetize
Fintech67%
Sudden Coffee, Inc.
Crystallized coffee that's better than fresh Starbucks
RetailingSeed$14.9M66%
Kaffea-X, Inc.Other TechnologySeed$1.2M65%
Stellar Sleep
We help people with chronic insomnia sleep better, using psychology.
65%
Lucy Goods, Inc
Lucy’s mission is to reduce tobacco-related harm to zero. We provide…
Biotech65%
Encepheal Therapeutics
EncepHeal develops medications to treat substance abuse, starting…
Biotech64%
Rhythmic Health, Inc.BiotechnologySeries A$162.7M64%
Frequently asked
How much funding has Rarebird, Inc. raised?
Rarebird, Inc. has raised approximately $9.0M in disclosed capital across 4 recorded financing rounds, aggregated from public filings.
What is Rarebird, Inc.'s estimated valuation?
Provath's modeled valuation for Rarebird, Inc. is approximately $2.9M (modeled range $1.2M–$5.8M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Rarebird, Inc. at?
Rarebird, Inc.'s latest modeled financing stage is Series A. Its most recent recorded round closed around Fri Oct 11.
What does Rarebird, Inc. do and where is it based?
Rarebird, Inc. operates in the Retailing sector, based in SAN FRANCISCO, CA, USA. Elevating mental health to be a part of your daily coffee ritual.
Explore related

See where Rarebird, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Rarebird, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.